| Literature DB >> 22373281 |
Brian J Morris1, Jake H Waskett, Joya Banerjee, Richard G Wamai, Aaron A R Tobian, Ronald H Gray, Stefan A Bailis, Robert C Bailey, Jeffrey D Klausner, Robin J Willcourt, Daniel T Halperin, Thomas E Wiswell, Adrian Mindel.
Abstract
BACKGROUND: Circumcision is a common procedure, but regional and societal attitudes differ on whether there is a need for a male to be circumcised and, if so, at what age. This is an important issue for many parents, but also pediatricians, other doctors, policy makers, public health authorities, medical bodies, and males themselves. DISCUSSION: We show here that infancy is an optimal time for clinical circumcision because an infant's low mobility facilitates the use of local anesthesia, sutures are not required, healing is quick, cosmetic outcome is usually excellent, costs are minimal, and complications are uncommon. The benefits of infant circumcision include prevention of urinary tract infections (a cause of renal scarring), reduction in risk of inflammatory foreskin conditions such as balanoposthitis, foreskin injuries, phimosis and paraphimosis. When the boy later becomes sexually active he has substantial protection against risk of HIV and other viral sexually transmitted infections such as genital herpes and oncogenic human papillomavirus, as well as penile cancer. The risk of cervical cancer in his female partner(s) is also reduced. Circumcision in adolescence or adulthood may evoke a fear of pain, penile damage or reduced sexual pleasure, even though unfounded. Time off work or school will be needed, cost is much greater, as are risks of complications, healing is slower, and stitches or tissue glue must be used.Entities:
Mesh:
Year: 2012 PMID: 22373281 PMCID: PMC3359221 DOI: 10.1186/1471-2431-12-20
Source DB: PubMed Journal: BMC Pediatr ISSN: 1471-2431 Impact factor: 2.125
Figure 1Forest plot showing association between circumcision and penile inflammation in 8 studies [38-45]. The meta-analysis shown does not include an anomalous outlier study [46], which when included led to significant between-study heterogeneity (P = 0.03), but when excluded no significant heterogeneity remained (P = 0.40).
A comprehensive risk-benefit analysis of infant MC
| Urinary tract infection (infants) | 1++ | 10 | 50 |
| Urinary tract infections (lifetime) | 2+ | 5 | 4 |
| Pyelonephritis (infants) | 2+ | 10 | 100 |
| - with concurrent bacteraemia | 2+ | 200 | 1000 |
| - childhood hypertension | 2 | - | 1500 |
| - end-stage renal disease (lifetime) | 2+ | - | 500 |
| Candidiasis | 2 | 2 | 10 |
| Prostate cancer | 2 | 1.5-2 | 6 |
| Balanitis | 2++ | 3 | 10 |
| Phimosis | 1++ | infinite | 10 |
| High-risk HPV | 1++ | 3 | 2 |
| Genital herpes (HSV-2) | 1+ | 1.35 | |
| Syphilis | 1+ | 3 | 200 |
| HIV infection | 1++ | 3-8 | 1000 |
| Penile cancer | 1++ | > 20 | 1000 |
| Cervical cancer | 1++ | 4 | - |
| Chlamydia | 2+ | 4 | - |
| HSV-2 | 2+ | 2 | - |
| Bacterial vaginosis | 1+ | 2 | - |
| Thus risk in an uncircumcised male of developing a condition requiring medical attention over their lifetime = 1 in 2 | |||
| Local bruising at site of injection of local anesthetic (if dorsal penile nerve block used) | 0.25* | 4 | |
| Infection, local | 0.002 | 600 | |
| Infection, systemic | 0.0002 | 4000 | |
| Excessive bleeding | 0.001 | 1000 | |
| Need for repeat surgery (if skin bridges or too little prepuce removed) | 0.001 | 1000 | |
| Loss of penis | close to 0 | 1 million | |
| Death | close to 0 | Over 1 million | |
| Loss of penile sensitivity | Low | High | |
| Thus risk of an easily-treatable condition = 1 in 500 and of a true complication = 1 in 5000 | |||
*As per Scottish Intercollegiate Guidelines Network (SIGN) grading system for evidence-based guidelines [87], which ranges from 1++ (highest) to 4 (lowest).
Values shown are based on statistics for USA (for source data see review [18] and references cited in the present article)
Abbreviations:
†NNT number needed to treat - i.e., approximate number of males who need to be circumcised to prevent one case of each condition associated with lack of circumcision.
††NNH number needed to harm, i.e., approximate number of males that need to be circumcised to see one of each particular (mostly minor) adverse effect. *The minor bruising (from this method only) disappears naturally without any need for medical intervention, so is not included in overall calculation of easily-treatable risks
Approximate figures for benefits of circumcision in infancy versus circumcision later
| UTI | 10 × | 5 × | birth, highest risk in 1st year of life |
| Phimosis | 5-infinity | 5-infinity | birth |
| Balanitis | 3 × | 3 × | birth, higher risk after onset of sexual activity |
| Hygiene | n/a | n/a | birth |
| HIV | 3-8 × | 3-8 × | onset of sexual activity |
| HPV | 2 × | 2 × | onset of sexual activity |
| HSV-2 | 1.3 × | 1.3 × | onset of sexual activity |
| Thrush | 2 × | 2 × | onset of sexual activity |
| Penile cancer | 3-22 × | less | protection level unclear if performed after childhood |
See main text for references to each condition
Complications and their frequency for medical MC of men in RCTs in South Africa (3.8%, all mild or moderate), Kenya (1.7%, all mild or moderate) and Uganda (4% mild, 3% moderate [breakdown not disclosed] and 1% severe [shown])
| Condition | South Africa | Kenya | Uganda |
|---|---|---|---|
| Bleeding post-op | 0.6% | 0.4% | 0.08% |
| Infection | 0.2% | 0.4% | 0.04% |
| Wound disruption | 0% | 0.3% | 0.04% |
| Delayed healing | 0.1% | 0.2% | -† |
| Swelling or hematoma | 0.6% | 0.1% | - |
| Severe pain | 0.8% | 0%* | - |
| Appearance problem | 0.6% | 0% | - |
| Damage to the penis | 0.3% | 0% | - |
| Too much skin removed | 0% | 0% | - |
| Too little skin removed | 0.3% | 0% | - |
| Anesthesia-related event | 0.06% | 0.1% | - |
| Problem urinating | 0% | 0% | - |
| Other | 0.3% | 0.4% | - |
| Death | 0% | 0% | - |
Refs: [56-58], respectively
*At the 3-day post-operative visit pain was zero in 48% of men, mild in 52% and severe in none
†Dashes indicate that the item was not reported in the publication